Pancreatic β-cells expressing GLP-1 are resistant to the toxic effects of immunosuppressive drugs

Journal of Molecular Endocrinology

Volumn 34, Issue 2, 2005, Pages 377-390

  D'Amico, Eugenio ^a,b   Hui, Hongxiang ^a,c   Khoury, Nasif ^a   Di Mario, Umberto ^d   Perfetti, Riccardo ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZOXIDE; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; IMMUNOSUPPRESSIVE AGENT; INSULIN; MYCOPHENOLIC ACID; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROGLUCAGON; PROTEIN BCL 2; PROTEIN P85; RAPAMYCIN; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; TACROLIMUS;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL COUNT; CELL CULTURE; CELL FUNCTION; CELL LINE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DIABETES MELLITUS; DRUG EXPOSURE; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC TRANSFECTION; GLUCOSE INTOLERANCE; GRAFT REJECTION; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; INSULIN RELEASE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RADIOIMMUNOASSAY; WESTERN BLOTTING;

ANIMALS; ANTIHYPERTENSIVE AGENTS; APOPTOSIS; CARRIER PROTEINS; CASPASE 3; CASPASES; CELL LINE, TUMOR; CELL SURVIVAL; DIAZOXIDE; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INSULIN; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISLETS OF LANGERHANS; MICE; MITOCHONDRIAL PROTEINS; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 17844365323     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.1.01655     Document Type: Article

References (32)

1. Bennet W, Sundberg B, Groth CG, Brencel MD, Brandhorst D, Brandhorst H, Bretzel RG, Elgue G, Larsson R, Nilsson B & Korsgren O 1999 Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes 48 1907-1912.
2. Contreras JL, Bilbao G, Smyth CA, Jiang XL, Eckhoff DE, Jenkins SM, Thomas FT, Curiel DT & Thomas JM 2001 Cytoprotection of pancreatic islets before and soon after transplantation by gene transfer of the anti-apoptotic Bcl-2 gene. Transplantation 71 1015-1023.
3. Drachenberg CB, Klassen DK, Weir MR, Wiland A, Fink JC, Bartlett ST, Cangro CB, Blahut S & Papadimitriou JC 1999 Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation. Transplantation 68 396-402.
4. Drucker DJ 2003 Glucagon-like peptides regulators of cell proliferation, differentiation, and apoptosis. Molecular Endocrinology 17 161-171.
5. During MJ, Cao L, Zuzga DS, Francis JS, Fitzsimons HL, Jiao X, Bland RJ, Klugmann M, Banks WA, Drucker DJ & Haile CN 2003 Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nature Medicine 9 1173-1179.
6. Fabian MC, Lakey JR, Rajotte RV & Kneteman NM 1992 Rapamycin prolongs murine islet al.lograft survival. Transplantation Proceedings 24 2842.
7. Farilla L, Hui H, Bertolotto C, Bulotta A, Kang E, Di Mario U & Perfetti R 2002 GLP-1 promotes islet cells growth and inhibits cell apoptosis in Zucker diabetic rats. Endocrinology 143 4397-4408.
8. Farilla L, Bulotta A, Hirshberg B, Li Calzi S, Khoury N, Noushmehr H, Bertolotto C, Di Mario U, Harlan DM & Perletti R 2003 Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. Endocrinology 144 5149-5158.
9. Hering B & Ricordi C 1999 Islet transplantation for patients with type 1 diabetes. Graft 2 12-27.
10. Herold KC, Nagamatsu S, Buse JB, Kulsakdinun P & Steiner DF 1993 Inhibition of glucose-stimulated insulin release from beta TC3 cells and rodent islets by an analog of FK506. Transplantation 55 186-192.
11. Hui H, Yu R, Bousquet C & Perfetti R 2002 Transfection of pancreatic-derived β-cells with a minigene encoding for human glucagon-like peptide-1 regulates glucose-dependent insulin synthesis and secretion. Endocrinology 143 3529-3539.
12. Hui H, Nourparvar A, Zhao X & Perfetti R 2003 Glucagon-Like Peptide-1 Inhibits Apoptosis of Insulin-Secreting Cells via a Cyclic 5′-Adenosine Monophosphate-Dependent Protein Kinase A-and a Phosphatidylinositol 3-Kinase-Dependent Pathway Endocrinology 144 1444-1455.
13. Hui H, Khoury N, Zhao, X, D'Amico E, Bulotta A, Nguyen E & Perfetti R 2004 Adenovirus-mediated XIAP gene transfer reverses the negative effects of immunosuppressive drugs on insulin secretion and viability of isolated human islets and MIN6 cells. 64th Annual Meeting of American Diabetes Association, Orlando, FL.
14. Hussain MA & Habener JF 2000 Glucagon-like peptide 1 increases glucose-dependent activity of the homeoprotein IDX-1 transactivating domain in pancreatic β-cells. Biochemical and Biophysical Research Communications 11 616-619.
15. Ishizuka J, Gugliuzza KK, Wassmuth Z, Hsieh J, Sato K, Tsuchiya T, Townsend CM Jr, Fish JC & Thompson JC 1993 Effects of FK506 and cyclosporine on dynamic insulin secretion from isolated dog pancreatic islets. Transplantation 56 1486-1490.
16. Kneteman NM, Lakey JR, Wagner T & Finegood D 1995 Beneficial metabolic impact of the novel immunosuppressant rapamycin in chronic canine islet autograft recipients. Transplantation Proceedings 27 3213-3217.
17. Lakey JR, Warnock GL, Shapiro AM, Korbutt GS, Ao Z, Kneteman NM & Rajotte RV 1999 Intraductal collagenase delivery into the human pancreas using syringe loading or controlled perfusion. Cell Transplant 8 285-292.
18. Li GD, Luo RH & Metz SA 2000 Effects of inhibitors of guanine nucleotide synthesis on membrane potential and cytosolic free Ca2+ levels in insulin-secreting cells. Biochemical Pharmacology 59 545-556.
19. Li Y, Hansotia T, Yusta B, Ris F, Halban PA & Drucker DJ 2003 Glucagon-like peptide-1 receptor signaling modulates β cell apoptosis. Journal of Biological Chemistry 278 471-478.
20. Meredith M, Li G & Metz SA 1997 Inhibition of calcium-induced insulin secretion from intact HIT-T15 or INS-1 beta cells by GTP depletion. Biochemical Pharmacology 53 1873-1882.
21. Patty BW, Harmon JS, Marsh LC & Robertson RP 2002 Inhibitory effect of immunosuppressive drugs on insulin secretion from HIT-T15 cells and Wistar rat islets. Transplantation 353-357.
22. Rabinovitch A, Suarez-Pinzon W, Strynadka K, Ju Q, Edelstein D, Brownlee M, Korbutt GS & Rajotte RV 1999 Transfection of human pancreatic islets with an anti-apoptotic gene (Bcl-2) protects beta-cells from cytokine-induced destruction. Diabetes 48 1223-1229.
23. Redmon JB, Olson LK, Armstrong MB, Greene MJ & Robertson RT 1996 Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells. Journal of Clinical Investigation 98 2786-2794.
24. Ricordi C, Tzakis A, Alejandro R, Zeng YJ, Demetris AJ, Carroll P, Mintz DH & Starzl TE 1991 In vivo effect of FK506 on human pancreatic islets. Transplantation 52 519-522.
25. Sato T, Inagaki A, Uchida K, Ueki T, Goto N, Matsuoka S, Katayama A, Haba T, Tominaga Y, Okajima Y, Ohta K, Suga H, Taguchi S, Kakiya S, Itatsu T, Kobayashi T & Nakao A 2003 Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy. Transplantation 76 1320-1326.
26. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM & Rajotte RV N 2000 Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. New England Journal of Medicine 343 230-238.
27. Strasser S, Alejandro R, Shapiro ET, Ricordi C, Todo S & Mintz DH 1992 Effect of FK506 on insulin secretion in normal dogs. Metabolism 41 64-67.
28. Sutherland DE, Gruessner RW, Dunn DL, Matas AJ, Humar A, Kandaswamy R, Mauer SM, Kennedy WR, Goetz FC, Robertson RP, Gruessner AC & Najarian JS 2001 Lessons learned from more than 1000 pancreas transplants at a single institution. Annals of Surgery 233 463-501.
29. The Diabetes Control and Complications Trial Research Group 1998 Effect of intensive therapy on residual β-cell function in patients with type 1 diabetes in the diabetes control and complications trial: a randomized, controlled trial. Annals of Internal Medicine 128 517-523.
30. Todd JF, Wilding JP, Edwards CM, Khan FA, Ghatei MA & Bloom SR 1997 Glucagon-like peptide-1 (GLP-1): a trial of treatment in non-insulin-dependent diabetes mellitus. European Journal of Clinical Investigation 27 533-536.
31. Uchida M, Hanai S, Uematsu N, Sawamoto K, Okano H, Miwa M & Uchida K 2001 Genetic and functional analysis of PARP, a DNA strand break-binding enzyme. Mutation Research 477 89-96.
32. Zeng Y, Ricordi C, Lendoire J, Carroll PB, Alejandro R, Bereiter DR, Tzakis A & Starzl TE 1993 The effect of prednisone on pancreatic islet autografts in dogs. Surgery 113 98-102.